US BANCORP \DE\ - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 206 filers reported holding BEAM THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.17 and the average weighting 0.3%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$48,677
+380.9%
2,024
+538.5%
0.00%
Q2 2023$10,122
-45.9%
317
-48.1%
0.00%
Q1 2023$18,709
+13.4%
611
+44.8%
0.00%
Q4 2022$16,504
-94.8%
422
-93.7%
0.00%
-100.0%
Q3 2022$319,000
+13.1%
6,709
-7.4%
0.00%0.0%
Q2 2022$282,000
-54.4%
7,248
-32.9%
0.00%0.0%
Q1 2022$619,000
-24.0%
10,802
+5.6%
0.00%0.0%
Q4 2021$815,000
-2.9%
10,231
+6.2%
0.00%
-50.0%
Q3 2021$839,000
-31.2%
9,631
+1.6%
0.00%0.0%
Q2 2021$1,219,000
+202.5%
9,478
+88.2%
0.00%
+100.0%
Q1 2021$403,000
+391.5%
5,037
+403.7%
0.00%
Q4 2020$82,000
+10.8%
1,000
-66.7%
0.00%
Q3 2020$74,0003,0000.00%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$205,573,00024.93%
HSG Holding Ltd 796,089$69,268,0006.22%
DC Investments Management, LLC 21,010$1,828,0003.41%
Redmile Group, LLC 1,975,006$171,845,0003.00%
Casdin Capital, LLC 818,820$71,246,0001.77%
Evolutionary Tree Capital Management, LLC 44,390$3,862,0001.71%
HHLR ADVISORS, LTD. 1,448,161$126,004,0001.65%
Nan Fung Group Holdings Ltd 54,903$4,777,0001.53%
ARK Investment Management 6,841,722$595,298,0001.43%
BRANDYWINE MANAGERS, LLC 12,900$1,122,0001.17%
View complete list of BEAM THERAPEUTICS INC shareholders